Sensei Biotherapeutics Inc (SNSE)
0.53
+0.01
(+2.51%)
USD |
NASDAQ |
Jan 08, 16:00
0.515
-0.02
(-2.83%)
Pre-Market: 08:03
Sensei Biotherapeutics SG&A Expense (Quarterly): 3.186M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Relmada Therapeutics Inc | 11.86M |
| Genprex Inc | 1.566M |
| Ensysce Biosciences Inc | 1.083M |
| IN8bio Inc | 2.732M |
| NovaBay Pharmaceuticals Inc | 2.65M |